Thomas C. Scanlon

发表

Bioengineered Lysozyme Reduces Bacterial Burden and Inflammation in a Murine Model of Mucoid Pseudomonas aeruginosa Lung Infection

C. Teneback, M. Wargo, K. Griswold, 2013, Antimicrobial Agents and Chemotherapy.

Progress in spinobulbar muscular atrophy research: Insights into neuronal dysfunction caused by the polyglutamine-expanded androgen receptor

B. Gottlieb, M. Trifiro, Thomas C. Scanlon, 2009, Neurotoxicity Research.

A high‐throughput screen for antibiotic drug discovery

K. Griswold, Thomas C. Scanlon, Sarah M Dostal, 2014, Biotechnology and bioengineering.

Enhanced antimicrobial activity of engineered human lysozyme.

J. Weiner, C. Teneback, A. Gill, 2010, ACS chemical biology.

Genetically enhanced lysozyme evades a pathogen derived inhibitory protein.

K. Griswold, Yongliang Fang, Thomas C. Scanlon, 2015, ACS chemical biology.

The monoclonal myth

K. Griswold, Elizabeth C Gray, Thomas C. Scanlon, 2010, Bioengineered bugs.

Quantifying and resolving multiple vector transformants in S. cerevisiae plasmid libraries

K. Griswold, Elizabeth C Gray, Thomas C. Scanlon, 2009, BMC biotechnology.

Isolation of human proteasomes and putative proteasome-interacting proteins using a novel affinity chromatography method.

B. Gottlieb, E. Fon, M. Trifiro, 2009, Experimental cell research.

Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor.

Xiaoling Wang, D. Merry, Erica S. Chevalier-Larsen, 2003, Human molecular genetics.

Bioengineered lysozyme in combination therapies for Pseudomonas aeruginosa lung infections

C. Teneback, M. Wargo, K. Griswold, 2014, Bioengineered.

Genetically Engineered Alginate Lyase-PEG Conjugates Exhibit Enhanced Catalytic Function and Reduced Immunoreactivity

M. Ackerman, K. Griswold, Jennifer I. Lai, 2011, PloS one.

Crystal Structure of a Charge Engineered Human Lysozyme Having Enhanced Bactericidal Activity

D. Madden, A. Gill, K. Griswold, 2011, PloS one.